loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 2491753 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) (1)

02 LAMIVUDINE (1)

filter

01 VIIV HEALTHCARE ULC (2)

filter

01 TABLET (2)

filter

01 300MG (1)

02 50MG (1)

filter

01 Canada (2)

URL Supplier Web Content
TABLET
300MG
DOVATO
Canada
2491753
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET
50MG
DOVATO
Canada
2491753
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2491753

Looking for CTD TGA MCC DOSSIER APPLICATION 2491753 2

19

ViiV Healthcare, based in United Kingdom, is a pharmaceutical company.

One of their notable products is LAMIVUDINE, with a corresponding application number 2491753 and regulatory information .

proudly manufactured in the

ViiV Healthcare's DOVATO TABLET, medication with 300MG of LAMIVUDINE.

18

ViiV Healthcare, based in United Kingdom, is a pharmaceutical company.

One of their notable products is DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM), with a corresponding application number 2491753 and regulatory information .

proudly manufactured in the

ViiV Healthcare's DOVATO TABLET, medication with 50MG of DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM).

Post Enquiry
POST ENQUIRY